Notifications

Home

Stocks
- Stock Screener
- Market Movers
- Insider Trades
- Upcoming Earnings
- Upcoming Dividends
Options
- Unusual Options Activity
- Implied Volatility Rank
- Volatility %Change
News
Upcoming IPOs

Medicus Pharma Ltd (MDCX)

$0.30 -0.04 (-10.68%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	14.09M
Revenue (ttm)	0.00
Net Income (ttm)	-35.46M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	1,411,700
Avg Vol	7,423,602
Day's Range	N/A - N/A
Shares Out	41.82M
Stochastic %K	47%
Beta	-0.47
Analysts	Strong Sell
Price Target	$6.50

Company Profile

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus P...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 610 636 0184

Website: medicuspharma.com

Address:

300 Conshohocken State Road, Suite 200, West Conshohocken, United States

Macarther May. 15 at 2:57 PM

$MDCX I’m loading up my bag, this stock will skyrocketing by the end of this month

1 · Reply

showmethemoney75 May. 15 at 2:15 PM

$MDCX New ATL today. With RS this will head to .15 as people get out before the vote

0 · Reply

Cullousus May. 15 at 11:30 AM

$MDCX consolidation...

0 · Reply

Moneyindabanknow May. 14 at 3:59 PM

$MDCX fill like this will be huge rocket soon.

0 · Reply

Sum_guy_69 May. 13 at 9:37 PM

$MDCX Run like $TDIC 🤯

0 · Reply

Sum_guy_69 May. 13 at 7:10 PM

$MDCX 🦅

0 · Reply

Macarther May. 12 at 4:45 PM

$MDCX This month full of upcoming news 🤌

1 · Reply

Sum_guy_69 May. 12 at 11:38 AM

$MDCX Have a good start to your day

0 · Reply

Gainermaxim May. 11 at 9:52 AM

$MDCX When FDA approval?

1 · Reply

Cullousus May. 10 at 3:18 AM

$MDCX consolidation leads to a run..

0 · Reply

Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response

Medicus Pharma meets with lawmakers to support SkinJect designations

2026-04-27T13:31:02.000Z - 18 days ago

Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan

Mar 25, 2026, 4:30 PM EDT - 7 weeks ago

Medicus Pharma Reports Full-Year 2025 Financial Results and Provides Corporate Update

2026-03-18T11:52:25.000Z - 2 months ago

Medicus Pharma to discuss Skinject Phase 2 reults in fireside chat

Mar 18, 2026, 7:30 AM EDT - 2 months ago

Medicus Pharma To Discuss Positive Skinject(R) Phase 2 Topline Results In Fireside Chat Hosted By Brookline Capital Markets Biotechnology Equity Research Analyst

2026-03-16T11:50:31.000Z - 2 months ago

Medicus Pharma announces SkinJect Phase 2 KOL update

Mar 16, 2026, 7:30 AM EDT - 2 months ago

Medicus Pharma Announces SkinJect® Phase 2 Principal Investigator and Key Opinion Leader (KOL), Babar K. Rao MD, FAAD, to Provide Clinical Interpretation of Positive Data During Business Update Webcast on March 26

Medicus Pharma Ltd. To Participate In The Longwood Miami CEO Forum

Mar 10, 2026, 7:30 AM EDT - 2 months ago

Medicus Pharma Reports Positive Phase 2 SKNJCT-003 Topline Data Observing 73% Clinical Clearance and 40% Histological Clearance (CR) at Day 57 in 200μg Cohort

Medicus Pharma To Participate in the 38th Annual Roth Conference

Mar 3, 2026, 7:30 AM EST - 2 months ago

Medicus Pharma Receives FDA “Study May Proceed” Clearance For Teverelix® Phase 2b Study in Advanced Prostate Cancer Patients with High Cardiovascular Risk

Jan 23, 2026, 7:30 AM EST - 4 months ago

Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony

2026-01-22T12:35:45.000Z - 4 months ago

Medicus announces amendment to LifeArc license improving Teverelix profile

Jan 22, 2026, 7:30 AM EST - 4 months ago

Medicus Pharma Ltd. Announces Amendment to LifeArc License Improving Teverelix® Long-Term Economic and Development Profile

Medicus Pharma Ltd. Celebrates One Year on Nasdaq with Opening Bell Ceremony on January 22, 2026

Jan 20, 2026, 7:30 AM EST - 4 months ago

Medicus Pharma Ltd. to Present at Biotech Showcase 2026 as SkinJect Phase 2 Clinical Data Approaches Readout and Partnering Readiness Accelerates

2025-12-22T12:46:17.000Z - 5 months ago

Medicus Pharma enters non-binding LOI with Reliant AI

Dec 22, 2025, 7:30 AM EST - 5 months ago

Medicus Pharma Ltd. Announces Engagement With Reliant AI to Develop Artificial Intelligence (AI) Driven Clinical Data Analytics Platform

2025-12-15T12:47:00.000Z - 5 months ago

Medicus Pharma completes enrollment of 90 patients for Phase 2 study

Dec 15, 2025, 7:30 AM EST - 5 months ago

Medicus Pharma Ltd. Completes Enrolment of Ninety (90) Patients for Phase 2 Clinical Study (SKNJCT-003) to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement

Dec 5, 2025, 3:20 PM EST - 5 months ago

Medicus Pharma Ltd. Announces Filing of FDA Commissioner's National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin

Nov 14, 2025, 5:00 PM EST - 6 months ago

Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights

Nov 13, 2025, 7:30 AM EST - 6 months ago

Medicus Pharma Ltd. Receives Full United Kingdom Regulatory and Ethical Approvals To Expand Phase 2 Clinical Study (SKNJCT-003) To Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin

Oct 29, 2025, 7:30 AM EDT - 7 months ago

Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for Skinject(TM) in Patients with Gorlin Syndrome

Oct 29, 2025, 7:30 AM EDT - 7 months ago

Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for SKINJECT™ in Patients with Gorlin Syndrome

Oct 22, 2025, 7:30 AM EDT - 7 months ago

Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin

The Vanderbilt Report: Medicus Pharma Ltd Built Three Separate Billion-Dollar Bets

Oct 14, 2025, 8:07 AM EDT - 7 months ago

Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject

Stonegate Capital Partners Initiates Coverage on Medicus Pharma Ltd. (MDCX)

Sep 24, 2025, 9:26 AM EDT - 8 months ago

Medicus Pharma Ltd. Provides Update on United Arab Emirates (UAE) SKNJCT-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

Sep 2, 2025, 7:30 AM EDT - 9 months ago

Medicus Pharma Ltd. Completes Acquisition of Antev Limited

Aug 21, 2025, 7:30 AM EDT - 9 months ago

Medicus Pharma Ltd. Provides Update on Doxorubicin Containing Novel Microneedle Array (D-MNA) Clinical Development Program for the Treatment of Basal Cell Carcinoma (BCC) of the Skin and Reports Second Quarter 2025 Financial Highlights

Aug 4, 2025, 7:30 AM EDT - 10 months ago

Medicus Pharma Ltd. Announces a Memorandum of Understanding (MOU) with Helix Nanotechnologies Inc. to Develop Thermostable Infectious Disease Vaccines

Medicus Pharma Ltd. Announces Voting Results Following the Annual and Special Meeting of Shareholders

Jul 23, 2025, 7:30 AM EDT - 10 months ago

1 · Reply

showmethemoney75 May. 15 at 2:15 PM

$MDCX New ATL today. With RS this will head to .15 as people get out before the vote

0 · Reply

Cullousus May. 15 at 11:30 AM

$MDCX consolidation...

0 · Reply

Moneyindabanknow May. 14 at 3:59 PM

$MDCX fill like this will be huge rocket soon.

0 · Reply

Sum_guy_69 May. 13 at 9:37 PM

$MDCX Run like $TDIC 🤯

0 · Reply

Sum_guy_69 May. 13 at 7:10 PM

$MDCX 🦅

0 · Reply

Macarther May. 12 at 4:45 PM

$MDCX This month full of upcoming news 🤌

1 · Reply

Sum_guy_69 May. 12 at 11:38 AM

$MDCX Have a good start to your day

0 · Reply

Gainermaxim May. 11 at 9:52 AM

$MDCX When FDA approval?

1 · Reply

Cullousus May. 10 at 3:18 AM

$MDCX consolidation leads to a run..

0 · Reply

WuTangMane May. 8 at 8:17 PM

$MDCX

0 · Reply

Macarther May. 8 at 8:11 PM

$MDCX big news come from FDA

0 · Reply

Girldadt May. 8 at 7:50 PM

$MDCX boom

0 · Reply

Girldadt May. 8 at 7:45 PM

$MDCX looking good lets go

0 · Reply

dumped_shitty_cxai May. 8 at 7:29 PM

$MDCX pamp et

0 · Reply

dumped_shitty_cxai May. 8 at 6:35 PM

$MDCX heck yea im up 20 percent now

0 · Reply

WuTangMane May. 8 at 6:14 PM

$MDCX boom

0 · Reply

Cullousus May. 8 at 5:32 PM

$MDCX

1 · Reply

WuTangMane May. 8 at 3:02 PM

$YMAT $MDCX $GCTK

0 · Reply

WuTangMane May. 8 at 12:11 PM

$MDCX consolidation and uptrend this afternoon into weekend

0 · Reply

Fire_Truck May. 7 at 5:38 PM

$MDCX They have till October 19 to regain compliance. I'll wait untill all the termoil to start before an entry. Probably right before the actual R/S date to be announced.

1 · Reply

1.0.0